📑Generic drugs - Tablets and capsules
Procurement process summary
This process is to purchase Generic drugs - Tablets and capsules.
This contract was awarded by 🇬🇧 eTenderwales for an amount of GBP 6,906 to 1 supplier. It was published on 2018-01-26 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇧 eTenderwales Buying unitnot reported Publication date2018-01-26 Contest statusnot reported DescriptionGeneric drugs - Tablets and capsules.Awards
This award was granted to Laboratories Almirall S.A. by eTenderwales for an amount of GBP 6,906. The procurement process was conducted through open for the category of goods. The award was granted on 2018-01-22. This is award number 20.
This contract has multiple awards. This is award number 20. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇬🇧 Laboratories Almirall S.A. | GBP 6,906 | 2018-01-22 | 20 |
Market context and opportunities
The execution of this contract allows the entity eTenderwales to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUK_ocds-70d2nz-9e963b6d-99be-4c1d-9afc-488d72180e4d-award-20Publication date2018-01-26Contract datenot reportedAward date2018-01-22CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
